Evidence map›Paper›PMID 23071307›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2012

Saving lives by training innate immunity with bacille Calmette-Guerin vaccine.

Peter Aaby, Christine Stabell Benn

Registry-linked trialAbstract readComment
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04534803 (Bacillus Calmette-Guerin Against Covid-19 for Prevention and Amelioration of Severity Trial), which is not on this map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04534803 phase3withdrawnnot on this mapstarted 2021, after this paper: background citation

Bacillus Calmette-Guerin Against Covid-19 for Prevention and Amelioration of Severity Trial

TypeinterventionalSponsorHarvard Medical School (HMS and HSDM)Ran2021 to 2022Enrolled0ConditionsCovid19ArmsBCG Vaccine, Placebo
3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Frontiers in immunology · 2025
    Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. NOD2-dependent BCG-induced trained immunity: A way to regulate innate responses to SARS-CoV2?International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2020
    Article
  20. Proposing BCG Vaccination forMicroorganisms · 2020
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Peter AabyResearch Center for Vitamins and Vaccines, Bandim Health Project, Statens Serum Institut, 2300 Copenhagen S, Denmark. p.aaby@bandim.org
Christine Stabell Benn

Funding

European Research Council 243149
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Epigenesis, GeneticBCG VaccineHumansMonocytesNod2 Signaling Adaptor ProteinBCG VaccineNOD2 protein, humanNod2 Signaling Adaptor Protein

Identifiers

PMID23071307
PMCPMC3491466

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.